Page last updated: 2024-08-23

captopril and amyloid beta-peptides

captopril has been researched along with amyloid beta-peptides in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Oba, R; Satoh, Y; Watanabe, A; Zou, K1
Hiraga, S; Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Takahashi, S; Tanabe, C; Terayama, Y; Watanabe, A; Zou, K1

Other Studies

2 other study(ies) available for captopril and amyloid beta-peptides

ArticleYear
Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
    The Journal of biological chemistry, 2009, Nov-13, Volume: 284, Issue:46

    Topics: Amyloid beta-Peptides; Angiotensins; Animals; Blotting, Western; Captopril; Catalytic Domain; Chlorocebus aethiops; COS Cells; Enalaprilat; Glycosylation; Humans; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2009
Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
    The American journal of pathology, 2013, Volume: 182, Issue:6

    Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Brain; Captopril; Case-Control Studies; Disease Progression; Humans; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Presenilins

2013